Overview

The Synergy Trial: Methylphenidate Plus a CFS-Specific Nutrient Formula as a Treatment for Chronic Fatigue Syndrome

Status:
Unknown status

Trial end date:
2014-12-01

Target enrollment:

Participant gender:

Summary

The Synergy Trial will evaluate the safety and efficacy of a currently available medication (methylphenidate hydrochloride) combined with a CFS-specific dietary supplement (CFS Nutrient Formula) to treat Chronic Fatigue Syndrome (CFS).

Phase:

Phase 2

Details

Lead Sponsor:

K-PAX Pharmaceuticals, Inc.

Treatments:

Methylphenidate